Regulatory updates, compliance insights, and industry analysis from the ACPL team.
CDSCO has tightened post-market surveillance for medical devices in 2026 — new MDSW guidance, 48-hour recall rules, and risk-based audits.…
Read MoreCDSCO Draft IVD Manufacturing Guidance 2026 | ACPL ACPLACCREDITED CONSULTANTS PVT. LTD.Visit ACPL Website Medical Device Regulatory Update · 9…
Read MoreCDSCO Export NOC for r-DNA Drugs: 2026 Update | ACPL ACPL ACCREDITED CONSULTANTS PVT. LTD. Visit ACPL Website Pharmaceutical Regulatory…
Read MoreCPCB has extended the FY 2025-26 battery EPR return deadline to 30 November 2026 while linking battery and e-waste compliance…
Read MoreCDSCO's new Prior Intimation pathway and interim import procedures are reshaping BA/BE study timelines in India. Here's what sponsors and…
Read MoreDGFT's 2026 notifications on antibiotic MIPs, SEZ import rules, and pharma intermediates are redrawing compliance lines for pharma, device, and…
Read MoreCPCB's Common EPR Portal cutover has reset plastic waste filing deadlines to October–December 2026. Here's what PIBOs and processors must…
Read MoreMedical Devices CDSCO Consultant in India
Read MoreIndia is amending the NDPS Act to introduce "proportionality" in enforcement. Here's what CBN's new self-regulation push and the Vision…
Read MoreLooking for a BIS Consultant in India? ACPL provides BIS certification, registration, documentation, compliance assessment and regulatory support for manufacturers,…
Read More